JournalThe Drink00 journal

The Power of Alcohol-Free

Why alcohol increases cancer risk, even at low levels

Why alcohol increases cancer risk, even at low levels

To begin

“A glass a day is good for you” is not a cancer-prevention recommendation. Alcohol is causally associated with cancers of the mouth, throat, larynx, oesophagus, liver, colorectum and female breast, and the risk can rise from low levels of consumption.

In France, a Santé publique France analysis estimated that 27,894 new cancer cases in 2015, or 7.9% of all new cases, were attributable to alcohol. This is a population-attributable estimate based on exposure and risk data; it is not a count of cases in which alcohol was individually proven to be the sole cause.

The useful question is not whether one drink guarantees cancer. It is how risk changes with exposure, why alcohol can cause cancer, and what lower-risk choices can and cannot achieve.

What the evidence says

Alcohol is a carcinogen, including at low levels

The International Agency for Research on Cancer classifies alcoholic beverages as carcinogenic to humans. The European Code Against Cancer identifies associations with cancers of the oral cavity, pharynx, larynx, oesophagus, liver, colorectum and female breast. The relationship is generally dose-related: more exposure tends to mean more risk, but a “safe” threshold for cancer prevention has not been established.

That does not mean that every person who drinks will develop cancer, or that one glass determines an individual outcome. It means that alcohol adds a preventable risk across a population. The World Cancer Research Fund statement therefore advises that, for cancer prevention, it is best not to drink alcohol.

France: a burden estimate, not an individual forecast

The Santé publique France analysis of 2015 new cases estimated 27,894 cases attributable to alcohol (95% uncertainty interval 24,287–30,996), or 7.9% of new cancer cases. The agency's public alcohol-and-health overview gives the wider context: alcohol-related cancer risk exists even at relatively low levels.

The estimate uses population exposure, relative risks and attributable fractions. It cannot say which drink caused a particular person's cancer, and it should not be converted into a personal percentage without age, sex, site, family history, smoking and other exposures.

How can alcohol contribute to cancer?

Several pathways, not one “toxin switch”

Alcohol is metabolised to acetaldehyde, which can damage DNA. Alcohol and its metabolites can also contribute to oxidative stress, affect folate metabolism and alter hormone signalling; chronic liver injury can create conditions in which liver cancer risk rises. These mechanisms overlap and vary by tissue and person. They do not justify a precise risk multiplier for every drinker.

At the mouth, pharynx, larynx and oesophagus, tobacco and alcohol can combine to create especially high risks. That interaction is real, but figures such as “15 to 35 times” or a fixed multiplier for every smoker and drinker are not transferable to every population or cancer site. The NEJM review is useful background on alcohol and health; it does not turn a population association into a personal diagnosis.

The myths that keep returning

“Red wine protects against cancer”

Polyphenols in grapes do not cancel ethanol. Some observational studies once associated moderate wine drinking with lower cardiovascular risk, but the comparison groups, former drinkers and other lifestyle differences make those findings difficult to interpret. For cancer prevention, no alcoholic beverage has a protective recommendation.

A quote attributed to Paracelsus—“the dose makes the poison”—is a historical idea, not a modern cancer threshold; the quotation source does not provide clinical evidence. The Inserm overview can be read alongside current cancer guidance, while the Lancet analysis illustrates why alcohol policy uses population-level risk rather than a promise of a harmless daily glass.

“One drink is too little to matter”

Risk is not an on/off switch. At low exposure, the absolute increase for one individual may be small, but it is not necessarily zero, and it differs by cancer site and baseline risk. An honest article should not present a universal “+2.5%” or “+5%” for every person, nor should it suggest that risk can be read from one isolated drink.

What happens after cutting down or stopping?

Risk can fall, but there is no universal countdown

The IARC review of alcohol and cancer reports evidence that reducing or stopping alcohol can reduce the risk of some cancers, with the clearest evidence for oral and oesophageal cancers. The time course depends on cancer site, previous exposure, smoking and other factors. No reliable fixed percentage or “all clear after X years” applies to everyone.

Stopping alcohol removes the exposure from future drinking; it does not erase previous exposure or guarantee that cancer will not occur. If someone has been drinking heavily or daily, abrupt withdrawal can be dangerous. A GP or addiction service can help plan a safer reduction or medically supervised withdrawal.

What do guidelines mean by “lower risk”?

France: limits are risk-reduction points, not a safe dose

French public-health guidance uses 10 g of pure alcohol as the reference for one standard drink and advises no more than 10 standard drinks per week, no more than 2 on a single day, with alcohol-free days. These are lower-risk benchmarks, not a level at which cancer risk becomes zero. The Santé publique France overview and the Inserm dossier provide French context.

Other countries use different definitions and advice. Canada's Guidance on Alcohol and Health describes one to two standard drinks per week as low risk, three to six as moderate risk and seven or more as increasingly high risk, with no more than two on any day. A Canadian standard drink is defined differently from the French 10-g reference, so the numbers must not be mixed. UK or Irish limits should likewise be read in their own local units.

Labels and public information

Ireland adopted the Public Health (Alcohol) (Labelling) Regulations 2023 under its Public Health (Alcohol) Act 2018. A later 2025 statutory instrument moved the implementation date to 3 September 2028 (official amended instrument). The date is a legal implementation detail, not evidence that Irish alcohol became more or less harmful.

A WHO Europe report on health warnings discusses public support and policy options. Survey averages should not be written as “all Europeans”, and a label informs a choice; it does not make the product safe.

What can a person do now?

If you drink, fewer occasions and fewer drinks reduce exposure. Alcohol-free days, alcohol-free alternatives and avoiding tobacco together with alcohol can lower risk, but “0.0” products still need their label checked and do not replace medical advice. Tremor or sweating after cutting down calls for prompt medical advice. Confusion, seizures or severe agitation require urgent medical care; do not try to manage these withdrawal symptoms alone.

For questions about a personal risk, talk to a GP or an addiction service. Policy and prevention work best when they communicate the graded evidence clearly: there is no proven cancer-protective dose of alcohol, and reducing exposure is a meaningful step without becoming a promise of individual certainty.

For the French policy debate, the article on why Emmanuel Macron does not support Dry January provides editorial context; it should not be used as a clinical source.

Sources

Alcohol is a preventable cause of several cancers, and the risk is not limited to people who drink heavily. French estimates attributed about 27,900 new cases in 2015 to alcohol, but that population figure cannot predict one person's future or assign a single cause to an individual tumour.

There is no alcoholic drink recommended for cancer prevention. Lowering intake reduces alcohol exposure and can reduce some risks over time. Stopping removes exposure from future drinking, without erasing past exposure or guaranteeing that cancer will not occur. French lower-risk limits are risk-management points, not a zero-risk threshold; if withdrawal may be a concern, seek medical support before stopping abruptly.